Regarding CRC, several molecular processes are implicated in the formation of CRC, including mutational inactivation of tumor-suppressor genes p53, adenomatous polyposis coli (APC), transforming growth factor-α (TGF-α), and activation of oncogene pathways (PI3K, RAS, and BRAF). This evidence concerns the gene TP53 and colorectal carcinoma.